230 related articles for article (PubMed ID: 15377822)
21. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
Malmström RE; Lundberg JM
Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
[TBL] [Abstract][Full Text] [Related]
22. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
Owen MP
J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
[TBL] [Abstract][Full Text] [Related]
23. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished?
Wahlestedt C; Håkanson R
Med Biol; 1986; 64(2-3):85-8. PubMed ID: 3018392
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay.
Straub RH; Schaller T; Miller LE; von Hörsten S; Jessop DS; Falk W; Schölmerich J
J Neurochem; 2000 Dec; 75(6):2464-71. PubMed ID: 11080198
[TBL] [Abstract][Full Text] [Related]
25. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
Hieble JP; Duesler JG; Daly RN
J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
Gonzalez-Montelongo MDC; Fountain SJ
Vascul Pharmacol; 2021 Feb; 136():106810. PubMed ID: 33181321
[TBL] [Abstract][Full Text] [Related]
27. Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
García-Villalón AL; Padilla J; Fernández N; Monge L; Martínez MA; Gómez B; Diéguez G
Pflugers Arch; 2000 Aug; 440(4):548-55. PubMed ID: 10958338
[TBL] [Abstract][Full Text] [Related]
28. Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y.
Franco-Cereceda A; Matran R; Alving K; Lundberg JM
Acta Physiol Scand; 1995 Oct; 155(2):193-204. PubMed ID: 8669292
[TBL] [Abstract][Full Text] [Related]
29. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
30. Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
Bradley E; Law A; Bell D; Johnson CD
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2007-14. PubMed ID: 12742824
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction.
Vu HQ; Budai D; Duckles SP
J Pharmacol Exp Ther; 1989 Dec; 251(3):852-7. PubMed ID: 2600818
[TBL] [Abstract][Full Text] [Related]
32. Neuropeptide Y and ATP interact to control renovascular resistance in the rat.
Oberhauser V; Vonend O; Rump LC
J Am Soc Nephrol; 1999 Jun; 10(6):1179-85. PubMed ID: 10361855
[TBL] [Abstract][Full Text] [Related]
33. Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP.
Lacroix JS; Stjärne P; Anggård A; Lundberg JM
Acta Physiol Scand; 1988 Jun; 133(2):183-97. PubMed ID: 3227914
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal sympatho-sensory control: functional role of nucleotides and calcitonin gene-related peptide in a peripheral neuroeffector junction.
Donoso MV; Hermosilla D; Navarrete C; Álvarez P; Lillo JG; Huidobro-Toro JP
Neuroscience; 2012 Feb; 203():216-29. PubMed ID: 22178987
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y (NPY) and sympathetic control of blood flow in oral mucosa and dental pulp in the cat.
Edwall B; Gazelius B; Fazekas A; Theodorsson-Norheim E; Lundberg JM
Acta Physiol Scand; 1985 Oct; 125(2):253-64. PubMed ID: 2866663
[TBL] [Abstract][Full Text] [Related]
36. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
Modin A
Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
[TBL] [Abstract][Full Text] [Related]
37. [Presynaptic regulation of co-release of neuropeptide Y and noradrenaline induced by electrical stimulation of the sympathetic nerve in guinea pig heart].
Cheng B; Haass M; Richardt G; Schömig A
Zhonghua Yi Xue Za Zhi; 1991 Oct; 71(10):564-7, 38. PubMed ID: 1665390
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission.
Lundberg JM; Franco-Cereceda A; Hemsén A; Lacroix JS; Pernow J
Fundam Clin Pharmacol; 1990; 4(4):373-91. PubMed ID: 2170253
[TBL] [Abstract][Full Text] [Related]
39. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers.
Ekblad E; Edvinsson L; Wahlestedt C; Uddman R; Håkanson R; Sundler F
Regul Pept; 1984 Apr; 8(3):225-35. PubMed ID: 6379758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
